Product Development Pipeline

Momenta product development pipeline


Momenta has generated a diversified development portfolio of complex generic, biosimilars, and novel drug candidates. Our pipeline is derived from our innovative technology, which we leverage to study the structure (characterization of chemical components), structure-process (design and control of manufacturing process) and structure-activity (relationship between structure and biological and clinical activity) of complex molecule drugs and biologics.



Lovenox® (enoxaparin sodium injection) is a registered trademark of Sanofi-Aventis. Copaxone® (glatiramer acetate) is a registered trademark of Teva Pharmaceutical Industries Ltd.


Last revised 3/26/2013